Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Combination of Cardonizumab with Lenvatinib and SOX regimen
Locations
1
China
Department of Gastric Surgery， Fujian Medical University Union Hospital
Fuzhou, Fujian, China
Start Date
January 1, 2023
Primary Completion Date
December 31, 2024
Completion Date
December 31, 2027
Last Updated
February 26, 2024
NCT07090525
NCT01291667
Lead Sponsor
Fujian Medical University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions